Insulin metabolism and the risk of Alzheimer disease: The Rotterdam Study

“Mini-mental state”

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · see citing works

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · see citing works

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944 · see citing works

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011 · see citing works

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity

Bonora, E., Targher, G., Alberiche, M., Bonadonna, R. C., Saggiani, F., Zenere, M. B., Monauni, T., & Muggeo, M. (2000) · Diabetes Care · doi:10.2337/diacare.23.1.57 · Cited by 2,456 · see citing works

Risk of dementia in diabetes mellitus: a systematic review

Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187 · see citing works

Diabetes mellitus and the risk of dementia: The Rotterdam Study

Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175 · see citing works

CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia

Roth, M., Tym, E., Mountjoy, C. Q., Huppert, F. A., Hendrie, H., Verma, S., & Goddard, R. (1986) · British Journal of Psychiatry · doi:10.1192/bjp.149.6.698 · Cited by 2,090 · see citing works

Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R)

Spitzer, R. L., & Williams, J. (1987) · Cited by 1,621 · see citing works

The Rotterdam Study: objectives and design update

Albert Hofman, D., Breteler, M. M. B., van Duijn, C. M., Krestin, G. P., Pols, H. A. P., Stricker, B. H. C., Tiemeier, H. W., Uitterlinden, A. G., Vingerling, J. R., & Witteman, J. C. M. (2007) · European Journal of Epidemiology · doi:10.1007/s10654-007-9199-x · Cited by 1,404 · see citing works

Type 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies

Peila, R., Rodriguez, B. L., & Launer, L. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1256 · Cited by 1,207 · see citing works

A semi-structured clinical interview for the assessment of diagnosis and mental state in the elderly: the Geriatric Mental State Schedule: I. Development and reliability

Copeland, J. R. M., Kelleher, M., Kellett, J. M., Gourlay, A. J., Gurland, B. J., Fleiss, J. L., & Sharpe, L. (1976) · Psychological Medicine · doi:10.1017/s0033291700015889 · Cited by 703 · see citing works

Hyperinsulinemia and risk of Alzheimer disease

Luchsinger, J. A., Tang, M.-X., Shea, S., & Mayeux, R. (2004) · Neurology · doi:10.1212/01.wnl.0000140292.04932.87 · Cited by 683 · see citing works

Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype

Reger, M. A., Watson, G. S., Frey, W. H., Baker, L. D., Cholerton, B., Keeling, M. L., Belongia, D., Fishel, M. A., Plymate, S. R., Schellenberg, G. D., et al. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.03.016 · Cited by 621 · see citing works

Test for additive interaction in proportional hazards models

Li, R., & Chambless, L. (2007) · Annals of Epidemiology · doi:10.1016/j.annepidem.2006.10.009 · Cited by 548 · see citing works

The Role of Metabolic Disorders in Alzheimer Disease and Vascular Dementia: Two Roads Converged

Craft, S. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.27 · Cited by 547 · see citing works

Diabetes, impaired fasting glucose, and development of cognitive impairment in older women

Yaffe, K., Blackwell, T., Kanaya, A. M., Davidowitz, N., Barrett-Connor, E., & Krueger, K. (2004) · Neurology · doi:10.1212/01.wnl.0000134666.64593.ba · Cited by 520 · see citing works

Incidence and Risk of Dementia: The Rotterdam study

Ott, A., Breteler, M. M. B., Harskamp, F. V., Stijnen, T., & Hofman, A. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009489 · Cited by 455 · see citing works

Estimating interaction on an additive scale between continuous determinants in a logistic regression model

Knol, M. J., van der Tweel, I., Grobbee, D. E., Numans, M. E., & Geerlings, M. I. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym157 · Cited by 444 · see citing works

Association between features of the insulin resistance syndrome and alzheimer's disease independently of apolipoprotein e4 phenotype: cross sectional population based study

Kuusisto, J., Koivisto, K. J., Mykkänen, L. M., Helkala, E.-L., Vanhanen, M., Hänninen, T., Kervinen, K., Kesäniemi, Y. A., Riekkinen, P. J., & Laakso, M. (1997) · BMJ · doi:10.1136/bmj.315.7115.1045 · Cited by 426 · see citing works

Diabetes mellitus and risk of dementia in the Kungsholmen project

Xu, W., Qiu, C., Wåhlin, Å., Winblad, B. G., & Fratiglioni, L. (2004) · Neurology · doi:10.1212/01.wnl.0000140291.86406.d1 · Cited by 409 · see citing works

Diabetes Mellitus and Risk of Developing Alzheimer Disease

Akomolafe, A., Beiser, A., Meigs, J. B., Au, R., Green, R. C., Farrer, L. A., Wolf, P. A., & Seshadri, S. S. (2006) · Archives of Neurology · doi:10.1001/archneur.63.11.1551 · Cited by 281 · see citing works

The Rotterdam Study: 2010 objectives and design update

Hofman, A., Breteler, M. M. B., van Duijn, C. M., Janssen, H. L. A., Krestin, G. P., Kuipers, E. J., Stricker, B. H. C., Tiemeier, H., Uitterlinden, A. G., Vingerling, J. R., et al. (2009) · European Journal of Epidemiology · doi:10.1007/s10654-009-9386-z · Cited by 244 · see citing works

Impaired insulin secretion increases the risk of Alzheimer disease

Rönnemaa, E., Zethelius, B., Sundelöf, J. E., Sundström, J., Degerman-Gunnarsson, M., Berne, C., Lannfelt, L., & Kilander, L. (2008) · Neurology · doi:10.1212/01.wnl.0000310646.32212.3a · Cited by 240 · see citing works

The Effect of Borderline Diabetes on the Risk of Dementia and Alzheimer’s Disease

Xu, W., Qiu, C., Winblad, B. G., & Fratiglioni, L. (2006) · Diabetes · doi:10.2337/db06-0879 · Cited by 218 · see citing works

Insulin Effects on Glucose Metabolism, Memory, and Plasma Amyloid Precursor Protein in Alzheimer's Disease Differ According to Apolipoprotein‐E Genotype

Craft, S., Asthana, S., Schellenberg, G. D., Baker, L. D., Cherrier, M. M., Boyt, A., Martins, R. N., Raskind, M. A., Peskind, E. R., & Plymate, S. R. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06371.x · Cited by 191 · see citing works

Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease

Luchsinger, J. A. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.02.048 · Cited by 171 · see citing works

Insulin Resistance Syndrome and Alzheimer Disease: Pathophysiologic Mechanisms and Therapeutic Implications

Craft, S. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213866.86934.7e · Cited by 167 · see citing works

Fasting insulin and incident dementia in an elderly population of Japanese-American men

Peila, R., Rodriguez, B. L., White, L. R., & Launer, L. J. (2004) · Neurology · doi:10.1212/01.wnl.0000129989.28404.9b · Cited by 152 · see citing works

Simple Automated Determination of Serum or Plasma Glucose by a Hexokinase/Glucose-6-Phosphate Dehydrogenase Method

Neeley, W. E. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.509 · Cited by 136 · see citing works

The relationship between type 2 diabetes and dementia

Strachan, M. W. J., Reynolds, R. M., Frier, B. M., Mitchell, R. J., & Price, J. F. (2008) · British Medical Bulletin · doi:10.1093/bmb/ldn042 · Cited by 109 · see citing works

Validity for epidemiological studies of long-term cryoconservation of steroid and protein hormones in serum and plasma.

BOLELLI, G., Muti, P. C., Micheli, A., Sciajno, R., Franceschetti, F., Krogh, V., Pisani, P., & Berrino, F. (1995) · PubMed · Cited by 106 · see citing works

A Prospective Analysis of Elevated Fasting Glucose Levels and Cognitive Function in Older People

Euser, S. M., Sattar, N. A., Witteman, J. C. M., Bollen, E. L. E. M., Sijbrands, E. J. G., Albert Hofman, D., Perry, I. J., Breteler, M. M. B., Westendorp, R. G. J., & Study, F. P. A. T. R. (2010) · Diabetes · doi:10.2337/db09-0568 · Cited by 89 · see citing works

Risk of Type 2 Diabetes Attributable to C-Reactive Protein and Other Risk Factors

Dehghan, A., van Hoek, M., Sijbrands, E. J. G., Stijnen, T., Albert Hofman, D., & Witteman, J. C. M. (2007) · Diabetes Care · doi:10.2337/dc07-0348 · Cited by 77 · see citing works

Experiences of the Janus Serum Bank in Norway.

Jellum, E., Andersen, A., Lund‐Larsen, P. G., Theodorsen, L., & Ørjasæter, H. (1995) · Environmental Health Perspectives · doi:10.1289/ehp.95103s385 · Cited by 73 · see citing works

Glucose metabolism and the risk of Alzheimer’s disease and dementia: a population-based 12 year follow-up study in 71-year-old men

Rönnemaa, E., Zethelius, B., Sundelöf, J. E., Sundström, J., Degerman-Gunnarsson, M., Lannfelt, L., Berne, C., & Kilander, L. (2009) · Diabetologia · doi:10.1007/s00125-009-1393-9 · Cited by 66 · see citing works

Experiences of the Janus Serum Bank in Norway

Jellum, E., Andersen, A., Lund‐Larsen, P. G., Theodorsen, L., & Ørjasæter, H. (1995) · Environmental Health Perspectives · doi:10.2307/3432566 · Cited by 26 · see citing works

Role of Insulin Metabolism Disturbances in the Development of Alzheimer Disease: Mini Review

Sabayan, B., Foroughinia, F., Mowla, A., & Borhani‐Haghighi, A. (2008) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317507312623 · Cited by 25 · see citing works

Minimally processed fresh frozen human reference sera: preparation, testing, and application to international external quality assurance

Henriksen, G. M., Pedersen, M., Nørgaard, I., Blom, M., Blou, L., Blaabjerg, O., & Uldall, A. (2004) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510410006612 · Cited by 22 · see citing works

Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline

Talbot, K., Wang, H.-Y., Kazi, H., Han, L.-Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59903 · Cited by 1,871 · see citing works

Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums

Arnold, S. E., Arvanitakis, Z., Macauley-Rambach, S. L., Koenig, A. M., Wang, H.-Y., Ahima, R. S., Craft, S., Gandy, S., Buettner, C., Stoeckel, L. E., et al. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.185 · Cited by 1,597 · see citing works

Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: Implications for diagnostic and therapeutic strategies

Chen, Z., & Zhong, C. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.004 · Cited by 671 · see citing works

Is Alzheimer’s disease a type 3 diabetes? A critical appraisal

Kandimalla, R., Thirumala, V., & Reddy, P. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.08.018 · Cited by 621 · see citing works

Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions

Biessels, G. J., Strachan, M. W. J., Visseren, F. L. J., Kappelle, L. J., & Whitmer, R. A. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70088-3 · Cited by 555 · see citing works

Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control

Lee, Y.-S., & Jun, H.-S. (2016) · Mediators of Inflammation · doi:10.1155/2016/3094642 · Cited by 503 · see citing works

Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice

Lin, B., Koibuchi, N., Hasegawa, Y., Sueta, D., Toyama, K., Uekawa, K., Ma, M., Nakagawa, T., Kusaka, H., & Kim-Mitsuyama, S. (2014) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0148-1 · Cited by 423 · see citing works

Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle–Aged Adults at Risk for Alzheimer Disease

Willette, A. A., Bendlin, B. B., Starks, E. J., Birdsill, A. C., Johnson, S. C., Christian, B. T., Okonkwo, O. C., La Rue, A., Hermann, B. P., Koscik, R. L., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.0613 · Cited by 418 · see citing works

Insulin and Insulin Resistance in Alzheimer’s Disease

Sędzikowska, A., & Szablewski, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189987 · Cited by 404 · see citing works

Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome

Kim, B., & Feldman, E. L. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2015.3 · Cited by 357 · see citing works

Risk factors associated with the onset and progression of Alzheimer's disease: a systematic review of the evidence

Hersi, M., Irvine, B., Gupta, P., Gomes, J., Birkett, N., & Krewski, D. (2017) · NeuroToxicology · doi:10.1016/j.neuro.2017.03.006 · Cited by 332 · see citing works

Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural‐derived blood exosomes of preclinical Alzheimer's disease

Kapogiannis, D., Boxer, A. L., Schwartz, J. B., Abner, E. L., Biragyn, A., Masharani, U. B., Frassetto, L. A., Petersen, R. C., Miller, B. L., & Goetzl, E. J. (2014) · The FASEB Journal · doi:10.1096/fj.14-262048 · Cited by 345 · see citing works

Altered Expression of Diabetes-Related Genes in Alzheimer's Disease Brains: The Hisayama Study

Hokama, M., Oka, S., Leon, J., Ninomiya, T., Honda, H., Sasaki, K., Iwaki, T., Ohara, T., Sasaki, T., LaFerla, F. M., et al. (2013) · Cerebral Cortex · doi:10.1093/cercor/bht101 · Cited by 319 · see citing works

Insulin resistance in the nervous system

Kim, B., & Feldman, E. L. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.12.004 · Cited by 321 · see citing works

High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice

Arnold, S. E., Lucki, I., Brookshire, B. R., Carlson, G. C., Browne, C. A., Kazi, H., Bang, S., Choi, B., Chen, Y., McMullen, M. F., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.03.011 · Cited by 315 · see citing works

Plasma nutrient status of patients with Alzheimer's disease: Systematic review and meta‐analysis

da Silva, S. L., Vellas, B. J., Elemans, S., Luchsinger, J. A., Kamphuis, P. J. G. H., Yaffe, K. S., Sijben, J., Groenendijk, M., & Stijnen, T. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.05.1771 · Cited by 311 · see citing works

Loss of motor function in preclinical Alzheimer's disease

Buchman, A. S., & Bennett, D. A. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.57 · Cited by 311 · see citing works

Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: Targets for disease modification?

Bassil, F., Fernagut, P., Bézard, E., & Meissner, W. G. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.02.005 · Cited by 313 · see citing works

Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration

Querfurth, H., & Lee, H.-K. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00428-5 · Cited by 288 · see citing works

Drug repositioning for Alzheimer's disease

Corbett, A., Pickett, J., Burns, A. S., Corcoran, J. P. T., Dunnett, S. B., Edison, P., Hagan, J. J., Holmes, C., Jones, E., Katona, C., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3869 · Cited by 302 · see citing works

Diabetes Mellitus and the Risk of Alzheimer’s Disease: A Nationwide Population-Based Study

Huang, C., Chung, C., Leu, H., Lin, L., Chiu, C.-C., Hsu, C., Chiang, C.-H., Huang, P., Chen, T., Lin, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087095 · Cited by 266 · see citing works

Insulin resistance predicts brain amyloid deposition in late middle‐aged adults

Willette, A. A., Johnson, S. C., Birdsill, A. C., Sager, M. A., Christian, B., Baker, L. D., Craft, S., Oh, J. M., Statz, E. H., Hermann, B. P., et al. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.03.011 · Cited by 262 · see citing works

Role of metabolism in neurodegenerative disorders

Procaccini, C., Santopaolo, M., Faicchia, D., Colamatteo, A., Formisano, L., de Candia, P., Galgani, M., De Rosa, V., & Matarese, G. (2016) · Metabolism · doi:10.1016/j.metabol.2016.05.018 · Cited by 258 · see citing works

A Brief Overview of Tauopathy: Causes, Consequences, and Therapeutic Strategies

Orr, M. E., Sullivan, A. C., & Frost, B. E. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.03.011 · Cited by 232 · see citing works

Altered glucose metabolism in Alzheimer's disease: Role of mitochondrial dysfunction and oxidative stress

Dewanjee, S., Chakraborty, P., Bhattacharya, H., Chacko, L., Singh, B., Chaudhary, A., Javvaji, K., Pradhan, S. R., Vallamkondu, J., Dey, A., et al. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.09.032 · Cited by 235 · see citing works

Insulin Reverses the High-Fat Diet–Induced Increase in Brain Aβ and Improves Memory in an Animal Model of Alzheimer Disease

Vandal, M., White, P. J., Tremblay, C., St‐Amour, I., Chevrier, G., Émond, V., Lefrançois, D., Virgili, J., Planel, E., Giguère, Y., et al. (2014) · Diabetes · doi:10.2337/db14-0375 · Cited by 232 · see citing works

Insulin Resistance, Brain Atrophy, and Cognitive Performance in Late Middle–Aged Adults

Willette, A. A., Xu, G., Johnson, S. C., Birdsill, A. C., Jonaitis, E. M., Sager, M. A., Hermann, B. P., Rue, A. L., Asthana, S., & Bendlin, B. B. (2012) · Diabetes Care · doi:10.2337/dc12-0922 · Cited by 220 · see citing works

Can Ketones Help Rescue Brain Fuel Supply in Later Life? Implications for Cognitive Health during Aging and the Treatment of Alzheimer’s Disease

Cunnane, S. C., Courchesne‐Loyer, A., Vandenberghe, C., St‐Pierre, V., Fortier, M., Hennebelle, M., Croteau, É., Bocti, C., Fülöp, T., & Castellano, C. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00053 · Cited by 224 · see citing works

Obesity as a risk factor for Alzheimer's disease: weighing the evidence

Alford, S., Patel, D. K., Perakakis, N., & Mantzoros, C. S. (2017) · Obesity Reviews · doi:10.1111/obr.12629 · Cited by 219 · see citing works

Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)

Femminella, G. D., Frangou, E., Love, S., Busza, G., Holmes, C., Ritchie, C. W., Lawrence, R., McFarlane, B., Tadros, G., Ridha, B. H., et al. (2019) · Trials · doi:10.1186/s13063-019-3259-x · Cited by 217 · see citing works

Drug repositioning and repurposing for Alzheimer disease

Ballard, C., Aarsland, D., Cummings, J., O’Brien, J., Mills, R., Molinuevo, J. L., Fladby, T., Williams, G., Doherty, P., Corbett, A., et al. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0397-4 · Cited by 201 · see citing works

Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimer's and Parkinson's disease models

Hölscher, C. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.040 · Cited by 201 · see citing works

AMPK activation: Role in the signaling pathways of neuroinflammation and neurodegeneration

Peixoto, C. A., Oliveira, W. H. D., Araújo, S. M. D. R., & Nunes, A. K. S. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.08.013 · Cited by 196 · see citing works

Cerebrovascular lesions induce transient  -amyloid deposition

Garcia-Alloza, M., Gregory, J., Kuchibhotla, K. V., Fine, S., Wei, Y., Ayata, C., Frosch, M. P., Greenberg, S. M., & Bacskai, B. J. (2011) · Brain · doi:10.1093/brain/awr300 · Cited by 187 · see citing works

Alzheimer's disease and metabolic syndrome: A link from oxidative stress and inflammation to neurodegeneration

Rojas-Gutierrez, E., Muñoz‐Arenas, G., Treviño, S., Espinosa, B., Chávez, R., Rojas, K., Flores, G., Díaz, A., & Guevara, J. (2017) · Synapse · doi:10.1002/syn.21990 · Cited by 193 · see citing works

The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer’s Disease

Hansen, H. H., Fabricius, K., Barkholt, P., Niehoff, M. L., Morley, J. E., Jelsing, J., Pyke, C., Knudsen, L. B., Farr, S. A., & Vrang, N. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-143090 · Cited by 189 · see citing works

Brain uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer’s and Parkinson’s disease therapeutics

Salameh, T. S., Rhea, E. M., Talbot, K., & Banks, W. A. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114187 · Cited by 188 · see citing works

Hypothalamic Alterations in Neurodegenerative Diseases and Their Relation to Abnormal Energy Metabolism

Vercruysse, P., Vieau, D., Blum, D., Petersén, Å., & Dupuis, L. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00002 · Cited by 172 · see citing works

Type 2 diabetes as a risk factor for cognitive impairment: current insights

Umegaki, H. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s48926 · Cited by 180 · see citing works

Impaired insulin signalling and allostatic load in Alzheimer disease

Felice, F. G. D., Gonçalves, R. A., & Ferreira, S. T. (2022) · Nature reviews. Neuroscience · doi:10.1038/s41583-022-00558-9 · Cited by 180 · see citing works

Does the brain shrink as the waist expands?

Willette, A. A., & Kapogiannis, D. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2014.03.007 · Cited by 162 · see citing works

Glucose Intolerance, Insulin Resistance, and Pathological Features of Alzheimer Disease in the Baltimore Longitudinal Study of Aging

Thambisetty, M., Metter, E. J., Yang, A., Dolan, H., Marano, C., Zonderman, A. B., Troncoso, J. C., Zhou, Y., Wong, D. F., Ferrucci, L., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.284 · Cited by 155 · see citing works

Vascular risk factors and cognitive impairment in a stroke-free cohort

Unverzagt, F. W., McClure, L. A., Wadley, V. G., Jenny, N. S., Go, R. C., Cushman, M., Kissela, B. M., Kelley, B. J., Kennedy, R., Moy, C. S., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318236ef23 · Cited by 152 · see citing works

Risk of Alzheimer’s Disease in Relation to Diabetes: A Population-Based Cohort Study

Wang, K.-C., Woung, L., Tsai, M.-T., Liu, C., Su, Y.-H., & Li, C. (2012) · Neuroepidemiology · doi:10.1159/000337428 · Cited by 148 · see citing works

Aging, lifestyle and dementia

Wahl, D., Solon‐Biet, S. M., Cogger, V. C., Fontana, L., Simpson, S. J., Couteur, D. G. L., & Ribeiro, R. V. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104481 · Cited by 151 · see citing works

Differential central pathology and cognitive impairment in pre-diabetic and diabetic mice

Ramos‐Rodríguez, J. J., Ortiz, O., Jiménez-Palomares, M., Kay, K. R., Berrocoso, E., Murillo-Carretero, M. I., Perdomo, G., Spires‐Jones, T. L., Cózar‐Castellano, I., Lechuga-Sancho, A. M., et al. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.05.010 · Cited by 146 · see citing works

Insulin resistance and cognitive dysfunction

Ma, L., Wang, J., & Li, Y. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.01.027 · Cited by 145 · see citing works

Serum Lipid Levels and the Risk of Intracerebral Hemorrhage: The Rotterdam Study

Wieberdink, R. G., Poels, M. M. F., Vernooij, M. W., Koudstaal, P. J., Albert Hofman, D., van der Lugt, A., Breteler, M. M. B., & Ikram, M. A. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.234948 · Cited by 138 · see citing works

Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer’s disease by exendin-4

Chen, S., Liu, A., An, F.-M., Yao, W., & Gao, X. (2011) · AGE · doi:10.1007/s11357-011-9303-8 · Cited by 136 · see citing works

Lower brain and blood nutrient status in Alzheimer's disease: Results from meta‐analyses

de Wilde, M. C., Vellas, B. J., Girault, E. M., Cetinyurek‐Yavuz, A., & Sijben, J. (2017) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.06.002 · Cited by 138 · see citing works

Aberrant Brain Functional Connectivity Related to Insulin Resistance in Type 2 Diabetes: A Resting-State fMRI Study

Chen, Y., Jiao, Y., Cui, Y., Shang, S., Ding, J., Feng, Y., Wen, S., Ju, S., & Teng, G. (2014) · Diabetes Care · doi:10.2337/dc13-2127 · Cited by 130 · see citing works

Obesity and insulin resistance are associated with reduced activity in core memory regions of the brain

Cheke, L. G., Bonnici, H. M., Clayton, N. S., & Simons, J. S. (2017) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2017.01.013 · Cited by 130 · see citing works

Exosomal biomarkers of brain insulin resistance associated with regional atrophy in Alzheimer's disease

Mullins, R. J., Mustapić, M., Goetzl, E. J., & Kapogiannis, D. (2017) · Human Brain Mapping · doi:10.1002/hbm.23494 · Cited by 128 · see citing works

The insulin resistance by triglyceride glucose index and risk for dementia: population-based study

Hong, S., Han, K., & Park, C. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00758-4 · Cited by 128 · see citing works

Risk of Dementia in Seniors With Newly Diagnosed Diabetes: A Population-Based Study

Haroon, N. N., Austin, P. C., Shah, B. R., Wu, J., Gill, S. S., & Booth, G. L. (2015) · Diabetes Care · doi:10.2337/dc15-0491 · Cited by 126 · see citing works

Mediterranean Diet in Preventing Neurodegenerative Diseases

Gardener, H., & Caunca, M. R. (2018) · Current Nutrition Reports · doi:10.1007/s13668-018-0222-5 · Cited by 124 · see citing works

Insulin resistance in Alzheimer's disease

Dineley, K. T., Jahrling, J. B., & Denner, L. A. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.09.001 · Cited by 124 · see citing works

Advanced Glycation End Products Modulate Amyloidogenic APP Processing and Tau Phosphorylation: A Mechanistic Link between Glycation and the Development of Alzheimer’s Disease

Batkulwar, K., Godbole, R. K., Banarjee, R., Kassaar, O., Williams, R. J., & Kulkarni, M. J. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00410 · Cited by 121 · see citing works

Brain Insulin Dysregulation: Implication for Neurological and Neuropsychiatric Disorders

Ghasemi, R., Dargahi, L., Haeri, A., Moosavi, M., Mohamed, Z., & Ahmadiani, A. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8404-z · Cited by 121 · see citing works

Insulin Resistance Predicts Medial Temporal Hypermetabolism in Mild Cognitive Impairment Conversion to Alzheimer Disease

Willette, A. A., Modanlo, N., Kapogiannis, D., & Initiative, A. D. N. (2015) · Diabetes · doi:10.2337/db14-1507 · Cited by 118 · see citing works

Hyperphosphorylation of Tau Induced by Naturally Secreted Amyloid-β at Nanomolar Concentrations Is Modulated by Insulin-dependent Akt-GSK3β Signaling Pathway

Tokutake, T., Kasuga, K., Yajima, R., Sekine, Y., Tezuka, T., Nishizawa, M., & Ikeuchi, T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.348300 · Cited by 117 · see citing works

Insulin Signaling Impairment in the Brain as a Risk Factor in Alzheimer’s Disease

Hölscher, C. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00088 · Cited by 105 · see citing works

Effects of dietary restriction on neuroinflammation in neurodegenerative diseases

Fontana, L., Ghezzi, L., Cross, A. H., & Piccio, L. M. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190086 · Cited by 116 · see citing works

Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer’s disease

Wakabayashi, T., Yamaguchi, K., Matsui, K., Sano, T., Kubota, T., Hashimoto, T., Mano, A., Yamada, K., Matsuo, Y., Kubota, N., et al. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0315-7 · Cited by 116 · see citing works

Circadian Rhythm and Alzheimer’s Disease

Homolak, J., Mudrovčić, M., Vukić, B., & Toljan, K. (2018) · Medical Sciences · doi:10.3390/medsci6030052 · Cited by 115 · see citing works

Unravelling the regulation of insulin transport across the brain endothelial cell

Gray, S. M., Aylor, K. W., & Barrett, E. J. (2017) · Diabetologia · doi:10.1007/s00125-017-4285-4 · Cited by 109 · see citing works

Role of Gut Microbiota in Obesity, Type 2 Diabetes and Alzheimer’s Disease

Naseer, M. I., Bibi, F., Al-Qahtani, M. H., Chaudhary, A., Azhar, E. I., Kamal, M. A., & Yasir, M. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660147 · Cited by 109 · see citing works

Blood‐based metabolic signatures in Alzheimer's disease

de Leeuw, F. A., Peeters, C. F. W., Kester, M. I., Harms, A. C., Struys, E. A., Hankemeier, T., van Vlijmen, H. W. T., van der Lee, S. J., van Duijn, C. M., Scheltens, P., et al. (2017) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2017.07.006 · Cited by 106 · see citing works

Age‐dependent impairment of glucose tolerance in the 3xTg‐AD mouse model of Alzheimer's disease

Vandal, M., White, P. J., Chevrier, G., Tremblay, C., St‐Amour, I., Planel, E., Marette, A., & Calon, F. (2015) · The FASEB Journal · doi:10.1096/fj.14-268482 · Cited by 103 · see citing works

Central Proliferation and Neurogenesis Is Impaired in Type 2 Diabetes and Prediabetes Animal Models

Ramos‐Rodríguez, J. J., Gil, S. M., Ortiz-Barajas, O., Jiménez-Palomares, M., Perdomo, G., Cózar‐Castellano, I., Lechuga-Sancho, A. M., & Garcı́a-Alloza, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089229 · Cited by 102 · see citing works

Association between Mediterranean diet and dementia and Alzheimer disease: a systematic review with meta-analysis

Nucci, D., Sommariva, A., Degoni, L., Gallo, G., Mancarella, M., Natarelli, F., Savoia, A., Catalini, A., Ferranti, R., Pregliasco, F. E., et al. (2024) · Aging Clinical and Experimental Research · doi:10.1007/s40520-024-02718-6 · Cited by 106 · see citing works

Longevity Pathways (mTOR, SIRT, Insulin/IGF-1) as Key Modulatory Targets on Aging and Neurodegeneration

Mazucanti, C. H., Cabral‐Costa, J. V., Vasconcelos, A. R., Andreotti, D. Z., Scavone, C., & Kawamoto, E. M. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150610125715 · Cited by 102 · see citing works

Mitochondria in Alzheimer's disease and their potential role in Alzheimer's proteostasis

Weidling, I. W., & Swerdlow, R. H. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113321 · Cited by 100 · see citing works

Insulin Resistance and Cognitive Impairment: Evidence From Neuroimaging

Cui, Y., Tang, T., Lu, C., & Ju, S. (2022) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.28358 · Cited by 103 · see citing works

Exenatide reduces TNF-α expression and improves hippocampal neuron numbers and memory in streptozotocin treated rats

Solmaz, V., Çınar, B. P., Yiğittürk, G., Çavuşoğlu, T., Taşkıran, D., & Erbaş, O. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.09.024 · Cited by 96 · see citing works

Lipid metabolism and neuroinflammation in Alzheimer’s disease: a role for liver X receptors

Kang, J., & Rivest, S. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1049 · Cited by 94 · see citing works

One for All? Hitting Multiple Alzheimer's Disease Targets with One Drug

Hughes, R. E., Nikolic, K. M., & Ramsay, R. R. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00177 · Cited by 92 · see citing works

Obesity as a risk factor for Alzheimer’s disease: the role of adipocytokines

Letra, L., Santana, I. J., & Seiça, R. M. F. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9501-z · Cited by 92 · see citing works

Leveraging electronic health records and knowledge networks for Alzheimer's disease prediction and sex-specific biological insights

Tang, A. S., Rankin, K. P., Cerono, G., Miramontes, S., Mills, H., Roger, J., Zeng, B., Nelson, C., Soman, K., Woldemariam, S., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00573-8 · Cited by 86 · see citing works

Increased Aβ production prompts the onset of glucose intolerance and insulin resistance

Jiménez-Palomares, M., Ramos‐Rodríguez, J. J., López-Acosta, J. F., Pacheco‐Herrero, M., Lechuga-Sancho, A. M., Perdomo, G., Garcı́a-Alloza, M., & Cózar‐Castellano, I. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00500.2011 · Cited by 89 · see citing works

Mediterranean diet and cognitive function: From methodology to mechanisms of action

Siervo, M., Shannon, O. M., Llewellyn, D. J., Stephan, B. C. M., & Fontana, L. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.09.018 · Cited by 86 · see citing works

Obesity, Insulin Resistance, and Alzheimer's Disease

Hildreth, K. L., Van Pelt, R. E., & Schwartz, R. S. (2012) · Obesity · doi:10.1038/oby.2012.19 · Cited by 86 · see citing works

Midlife insulin resistance, APOE genotype, and late-life brain amyloid accumulation

Ekblad, L. L., Johansson, J. J., Helin, S., Viitanen, M. H., Laine, H. K., Puukka, P. J., Jula, A., & Rinne, J. O. (2018) · Neurology · doi:10.1212/wnl.0000000000005214 · Cited by 84 · see citing works

Functions of amyloid precursor protein in metabolic diseases

Guo, Y., Wang, Q., Chen, S., & Xu, C. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154454 · Cited by 83 · see citing works

Inflammasome NLRP3 Potentially Links Obesity-Associated Low-Grade Systemic Inflammation and Insulin Resistance with Alzheimer’s Disease

Litwiniuk, A., Bik, W., Kalisz, M., & Baranowska-Bik, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115603 · Cited by 82 · see citing works

Insulin Resistance is Associated with Increased Levels of Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease and Reduced Memory Function in At-Risk Healthy Middle-Aged Adults

Hoscheidt, S. M., Starks, E. J., Oh, J. M., Zetterberg, H., Blennow, K., Krause, R. A., Gleason, C. E., Puglielli, L., Atwood, C., Carlsson, C. M., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160110 · Cited by 82 · see citing works

SIRT3 activator Honokiol attenuates β-Amyloid by modulating amyloidogenic pathway

Ramesh, S., Govindarajulu, M., Lynd, T. O., Briggs, G. H., Adamek, D., Jones, E., Heiner, J., Majrashi, M., Moore, T., Amin, R., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190350 · Cited by 81 · see citing works

Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease

Johansson, P., Åberg, D., Johansson, J.-O., Mattsson, N., Hansson, O., Åhrén, B., Isgaard, J., Åberg, N. D., Blennow, K., Zetterberg, H., et al. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.02.006 · Cited by 79 · see citing works

Impaired peripheral glucose homeostasis and Alzheimer's disease

Wijesekara, N., Gonçalves, R. A., Felice, F. G. D., & Fraser, P. E. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.027 · Cited by 80 · see citing works

GLP-1 receptor agonists show neuroprotective effects in animal models of diabetes

Gault, V. A., & Hölscher, C. (2018) · Peptides · doi:10.1016/j.peptides.2017.11.017 · Cited by 80 · see citing works

Cellular and metabolic alterations in the hippocampus caused by insulin signalling dysfunction and its association with cognitive impairment during aging and Alzheimer's disease: studies in animal models

Calvo‐Ochoa, E., & Arias, C. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2531 · Cited by 80 · see citing works

Amelioration of Metabolic Syndrome-Associated Cognitive Impairments in Mice via a Reduction in Dietary Fat Content or Infusion of Non-Diabetic Plasma

Johnson, L. A., Zuloaga, K. L., Kugelman, T., Mader, K. S., Morré, J. T., Zuloaga, D. G., Weber, S. J., Marzulla, T., Mulford, A., Button, D. A., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.12.008 · Cited by 73 · see citing works

Health-Promoting Strategies for the Aging Brain

Chen, S. T., Volle, D. C., Jalil, J., Wu, P., & Small, G. W. (2018) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.12.016 · Cited by 74 · see citing works

Altered APP Processing in Insulin-Resistant Conditions Is Mediated by Autophagosome Accumulation via the Inhibition of Mammalian Target of Rapamycin Pathway

Son, S., Song, H., Byun, J., Park, K., Jang, H., Park, Y., & Mook-Jung, I. (2012) · Diabetes · doi:10.2337/db11-1735 · Cited by 74 · see citing works

Neuronal stress signaling and eIF2α phosphorylation as molecular links between Alzheimer's disease and diabetes

Lourenco, M. V., Ferreira, S. T., & Felice, F. G. D. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.03.003 · Cited by 71 · see citing works

DPP-4 inhibition with linagliptin ameliorates cognitive impairment and brain atrophy induced by transient cerebral ischemia in type 2 diabetic mice

Ma, M., Hasegawa, Y., Koibuchi, N., Toyama, K., Uekawa, K., Nakagawa, T., Lin, B., & Kim‐Mitsuyama, S. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0218-z · Cited by 72 · see citing works

Multi Targeted Therapy for Alzheimer’s Disease by Guanidinium-Modified Calixarene and Cyclodextrin Co-Assembly Loaded with Insulin

Zhang, Q., Wang, Q., Fu, J., Xu, X., Guo, D., Pan, Y., Zhang, T., & Wang, H. (2024) · ACS Nano · doi:10.1021/acsnano.4c05693 · Cited by 69 · see citing works

Central vascular disease and exacerbated pathology in a mixed model of type 2 diabetes and Alzheimer's disease

Ramos‐Rodríguez, J. J., Jiménez-Palomares, M., Murillo-Carretero, M. I., Infante‐Garcia, C., Berrocoso, E., Pacho, F. H., Lechuga-Sancho, A. M., Cózar‐Castellano, I., & Garcı́a-Alloza, M. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.07.606 · Cited by 67 · see citing works

The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer’s Dementia

Folch, J., Olloquequi, J., Ettcheto, M., Busquets, O., Sánchez‐López, E., Cano, A. C., Espinosa-Jiménez, T., García, M. L., Beas‐Zárate, C., Casadesús, G., et al. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00236 · Cited by 68 · see citing works

The Dual GLP-1/GIP Receptor Agonist DA4-JC Shows Superior Protective Properties Compared to the GLP-1 Analogue Liraglutide in the APP/PS1 Mouse Model of Alzheimer’s Disease

Maskery, M. P., Goulding, E. M., Gengler, S., Melchiorsen, J. U., ROSENKILDE, M. M., & Hölscher, C. (2020) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317520953041 · Cited by 67 · see citing works

P3‐134: Insulin metabolism and the risk of Alzheimer's disease: The Rotterdam Study

Schrijvers, E. M. C., Witteman, J. C. M., Sijbrands, E. J. G., Albert Hofman, D., Koudstaal, P. J., & Breteler, M. M. B. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.04.1109

S3‐01‐04: Insulin metabolism and the risk of dementia and Alzheimer's disease

Breteler, M. M. B. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.2360

Impaired insulin secretion increases the risk of Alzheimer disease

Rönnemaa, E., Zethelius, B., Sundelöf, J. E., Sundström, J., Degerman-Gunnarsson, M., Berne, C., Lannfelt, L., & Kilander, L. (2008) · Neurology · doi:10.1212/01.wnl.0000310646.32212.3a · Cited by 240 · see citing works

Glucose Metabolism and Insulin Action in Alzheimer’s Disease Pathogenesis

Bosco, D., Plastino, M., Spano, A. L., Ermio, C., & Fav, A. (2011) · InTech eBooks · doi:10.5772/23138 · Cited by 1 · see citing works

P1–234: Diabetes, insulin resistance and risk of Alzheimer's disease

Rönnemaa, E., Sundström, J., Sundelöf, J. E., Degerman-Gunnarsson, M., Zethelius, B., Berne, C., Kilander, L., & Lannfelt, L. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.611